Pharmaceutical Technology

DECEMBER 5, 2022

CB1 receptors are primarily expressed in the brain and central nervous system, whereas CB2 receptors are expressed in T-cells in the immune system. Collectively, cannabinoid receptors (CB1 and CB2) are currently the most popular targets in preclinical stage of development, with 391 drugs tagged in total.

Regulation 245

Regulation Drugs Development Marketing 245

Drug Discovery World

JANUARY 9, 2023

In this early research, Khalid Shah, Professor of Neurosurgery at Harvard Medical School and Brigham and Women’s Hospital, and colleagues tested the vaccine in an advanced mouse model of brain cancer glioblastoma, with promising results. The findings are published in Science Translational Medicine. . CRISPR-Cas9 gene editing .

Scientist 52

Scientist Gene Editing Gene Engineer 52

Delveinsight

FEBRUARY 25, 2021

GRAIL and Quest collaborate for the cancer blood test. Cancer detection company GRAIL has announced a collaboration with Quest Diagnostics that sees Quest proffering phlebotomy services to bolster GRAIL’s multi-cancer early detection blood test Galleri. Brain organoids grown in the lab mimic infant’s brains.

DNA 52

DNA In-Vivo Genetics Medicine 52

The Pharma Data

OCTOBER 9, 2021

This designation is predicated on data showing that gantenerumab significantly reduced brain amyloid pillar, a pathological hallmark of Notice, in the ongoing SCarlet RoAD and Marguerite RoAD open- tag extension trials, as well as other studies.

Antibody 52

Antibody In-Vitro Trials Development 52

XTalks

OCTOBER 12, 2022

Features of blood perfusion in the brain detected by MRI now have clinical applications in central nervous system (CNS) cancers, neurodegenerative disease, cerebrovascular disease and demyelinating disease. That is easy to implement for brain perfusion imaging because all the blood getting into the brain is coming through the neck.

Clinical Trials 93

Clinical Trials Clinical Trials Trials Drugs 93

XTalks

SEPTEMBER 27, 2022

The record-breaking price tag of Skysona is not surprising for one-time gene therapies like it. CALD is caused by mutations in the ABCD1 gene that affect the production of adrenoleukodystrophy protein (ALDP), which leads to the accumulation of very long-chain fatty acids (VLCFAs), mainly in the white matter of the brain and spinal cord.

FDA Approval 52

FDA Approval Gene Therapy Drugs Gene 52

Drug Discovery World

NOVEMBER 9, 2023

Advances in discovery and engineering of antibodies for non-cancer targets This session will feature a range of presentations which include: Joshua Tan, PhD, Chief, Antibody Biology Unit, National Institute of Allergy and Infectious Diseases, National Institutes of Health, on: ‘Discovery of broadley-neutralising antibodies against Coronaviruses’.

Engineer 52

Engineer Antibody Protein In-Vivo 52